GI bleeding after percutaneous coronary intervention among patients on dual antiplatelet therapy remains risky in terms of ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

Dual antiplatelet therapy with clopidogrel and aspirin can benefit patients with mild ischemic stroke when initiated up to 72 hours after symptom onset.

Additionally, patients with permanent metal implants often require prolonged antiplatelet therapy, which increases the risk of bleeding complications. In response to these limitations, metal-free PCI ...

Genomadix (genomadix.com), a global leader in point of need precision medicine diagnostics, announced today that it has entered into a know-how license agreement with Mayo Clinic to collaborate on the ...

This unique dual formulation provides the potential benefit for smooth transition from short-term intravenous to long-term oral antiplatelet therapy. It has a plasma half-life of approximately 12 ...

Background: There are currently no specific guidelines regarding pre-hospital antiplatelet therapy in patients with out-of-hospital cardiac arrest (OHCA) suspected of acute coronary syndrome (ACS).

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) warranting optimized management.

Introduction: Antiplatelet therapy with aspirin has been recommended for patients with stroke and myocardial infarction (MI). Clinicians face challenges when they come across aspirin hypersensitivity ...

Successful MDSAP certification confirms compliance with Health Canada and U.S. FDA quality management system requirements, replacing FDA audit and inspection if required Health Canada and U.S. FDA ...

Ioannis Merinopoulos and colleagues suggest that the potential benefit of the preventive percutaneous coronary intervention on vulnerable plaque might be partly attributed to a higher use of dual ...